LLY News and Press, Eli Lilly and Company From 05/26/24

2024-05-26 10:15:00 ET Summary Parnassus Investments is a fundamental, bottoms-up investment firm offering responsible investment funds to the public. Parnassus Investments integrates comprehensive ESG evaluations with fundamental financial analysis to select investments. The Fund...

2024-05-26 06:53:00 ET With some promising clinical trial results in hand and more that could be on the way relatively soon, Amgen 's (NASDAQ: AMGN) latest attempt to develop a therapy for obesity is looking like it could be a contender for the crown that's currently jointly held by...

2024-05-25 10:24:03 ET More on AbbVie, Amgen, etc. Bristol Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying Opportunity Why Gilead Sciences' 4.6% Yield Doesn't Make The Cut For Smart Investors Amgen Stock: Poised To Break Out (Techni...

2024-05-25 06:47:00 ET What's better than a stock that has delivered huge gains? That's easy: A stock that has delivered huge gains and still has a lot of room to run. We asked three Motley Fool contributors to look among recently high-flying stocks for those that they believe could...

2024-05-24 16:16:00 ET More on Novo Nordisk Novo weight loss therapy cuts mortality risk in kidney disease SA Asks: Is Eli Lilly or Novo Nordisk a better investment? The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings C...

2024-05-24 14:48:52 ET Summary The stock of Cytokinetics, Incorporated plunged 17% in trading on Thursday, largely as the result of a somewhat botched capital raise announcement. The capital raise took a near-term buyout off the table in the short term and left many shareholders f...

2024-05-24 10:40:44 ET More on Zealand Pharma Zealand Pharma A/S (ZLDPF) Q1 2024 Earnings Call Transcript Zealand Pharma: Survodutide Has Potential Beyond Obesity Treatment Zealand Pharma A/S (ZEAL) Q4 2023 Earnings Call Transcript Historical earnings data fo...

2024-05-24 10:10:36 ET More on Eli Lilly Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly Remains Expensive Here - Minimal Margin Of Safety Eli Lilly: Don't Overpay For Miracle Drugs SA Asks: Is Eli Lilly or Novo Nordisk a better invest...

Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines PR Newswire Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history Since 20...

2024-05-24 09:17:15 ET Summary Medifast's financial performance is deteriorating rapidly due to the emergence of drug-weight loss competitors. The company reported a significant decline in revenue and earnings in Q1 2023. Medifast is laying off employees and may need to furthe...